Shandong Zhangqiu Blower Co., Ltd (SHE:002598)

Verve Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	241.97	250.57	354.06	149.37	91.68	68.84
Trading Asset Securities	54.91	127.2	36.95	61.61	132.07	111.3
Cash & Short-Term Investments	296.88	377.77	391.01	210.98	223.75	180.15
Cash Growth	-22.75%	-3.38%	85.33%	-5.71%	24.20%	38.17%
Accounts Receivable	1,336	1,447	1,210	1,061	986.01	522.68
Other Receivables	28.3	26.74	26.06	26.78	21.39	18.39
Receivables	1,364	1,474	1,236	1,087	1,007	541.07
Inventory	451.26	426.29	431.77	498.18	497.76	427.96
Prepaid Expenses	-	-	-	-	1	0.09
Other Current Assets	82.52	78.71	79.38	63.28	78.75	38.31
Total Current Assets	2,195	2,356	2,138	1,860	1,809	1,188
Property, Plant & Equipment	283.02	288.82	240.5	209.46	200.5	194.42
Long-Term Investments	292.25	281.85	260.38	250.84	143.97	110.17
Goodwill	49.86	49.86	49.86	49.86	49.86	49.86
Other Intangible Assets	62.1	63.91	62.25	58.16	49.52	50.29
Long-Term Deferred Tax Assets	21	24.17	19.48	17.38	10.5	8.04
Long-Term Deferred Charges	37.35	41.88	18.05	18.65	7.9	10.7
Other Long-Term Assets	44.91	40.94	58.21	86.12	7.49	-
Total Assets	2,985	3,148	2,847	2,550	2,278	1,611
Accounts Payable	572.97	581.06	405.9	389.86	313.03	270.48
Accrued Expenses	20.39	59.74	61.53	65	35.24	26.52
Short-Term Debt	236	408.37	321	362.06	368.49	180
Current Portion of Long-Term Debt	29.5	57.59	123.1	7.06	-	-
Current Income Taxes Payable	6.77	1.45	7.41	4.08	0.65	1.89
Current Unearned Revenue	182.41	117.26	139.69	160.89	174.14	160.41
Other Current Liabilities	325.37	331.63	301.4	345.48	348.46	44.39
Total Current Liabilities	1,373	1,557	1,360	1,334	1,240	683.68
Long-Term Debt	235.15	235.15	189.3	92	-	-
Long-Term Unearned Revenue	14.53	15.36	14.42	16.74	19.04	16.7
Long-Term Deferred Tax Liabilities	1.93	1.93	1.4	1.64	1.89	2.15
Total Liabilities	1,625	1,810	1,565	1,445	1,261	702.54
Common Stock	312.03	312.03	312	312	312	312
Additional Paid-In Capital	212.03	212.03	211.7	211.7	211.7	211.7
Retained Earnings	673.17	652.34	610.66	535.31	456.34	351.44
Comprehensive Income & Other	98.29	98.29	93.09	8.61	3.51	2.7
Total Common Equity	1,296	1,275	1,227	1,068	983.54	877.83
Minority Interest	64.62	63.5	54.4	37.95	33.91	30.69
Shareholders' Equity	1,360	1,338	1,282	1,106	1,017	908.52
Total Liabilities & Equity	2,985	3,148	2,847	2,550	2,278	1,611
Total Debt	500.65	701.1	633.4	461.12	368.49	180
Net Cash (Debt)	-203.76	-323.33	-242.39	-250.14	-144.73	0.15
Net Cash Growth	-	-	-	-	-	-99.63%
Net Cash Per Share	-0.65	-1.02	-0.78	-0.80	-0.46	0.00
Filing Date Shares Outstanding	312.03	312.03	312	312	312	312
Total Common Shares Outstanding	312.03	312.03	312	312	312	312
Working Capital	821.26	799.2	778.24	525.49	568.66	503.89
Book Value Per Share	4.15	4.09	3.93	3.42	3.15	2.81
Tangible Book Value	1,184	1,161	1,115	959.6	884.17	777.69
Tangible Book Value Per Share	3.79	3.72	3.57	3.08	2.83	2.49
Buildings	-	232.62	207.73	186.02	178.05	177.71
Machinery	-	320.45	296.42	269.32	250.98	235.07
Construction In Progress	-	28.86	13.13	8.14	7.38	0.1

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.